1
|
Osoegawa A, Yoshino I, Tanaka S, Sugio K,
Kameyama T, Yamaguchi M and Maehara Y: Regulation of p27 by S-phase
kinase-associated protein 2 is associated with aggressiveness in
non-small-cell lung cancer. J Clin Oncol. 22:4165–4173. 2004.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Gstaiger M, Jordan R, Lim M, Catzavelos C,
Mestan J, Slingerland J and Krek W: Skp2 is oncogenic and
overexpressed in human cancers. Proc Natl Acad Sci USA.
98:5043–5048. 2001. View Article : Google Scholar : PubMed/NCBI
|
3
|
Nakayama KI, Hatakeyama S and Nakayama K:
Regulation of the cell cycle at the G1-S transition by proteolysis
of cyclin E and p27Kip1. Biochem Biophys Res Commun. 282:853–860.
2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Nakayama K, Nagahama H, Minamishima YA,
Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R,
Tsukiyama T, Ishida N, et al: Targeted disruption of Skp2 results
in accumulation of cyclin E and p27(Kip1), polyploidy and
centrosome overduplication. EMBO J. 19:2069–2081. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sicari BM, Troxell R, Salim F, Tanwir M,
Takane KK and Fiaschi-Taesch N: c-myc and skp2 coordinate p27
degradation, vascular smooth muscle proliferation, and neointima
formation induced by the parathyroid hormone-related protein.
Endocrinology. 153:861–872. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Suzuki S, Fukasawa H, Misaki T, Togawa A,
Ohashi N, Kitagawa K, Kotake Y, Liu N, Niida H, Nakayama K, et al:
The amelioration of renal damage in Skp2-deficient mice canceled by
p27 Kip1 deficiency in Skp2−/− p27−/− mice.
PLoS One. 7:e362492012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lim MS, Adamson A, Lin Z, Perez-Ordonez B,
Jordan RC, Tripp S, Perkins SL and Elenitoba-Johnson KS: Expression
of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma:
Correlation with p27(Kip1) and proliferation index. Blood.
100:2950–2956. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wang Z, Gao D, Fukushima H, Inuzuka H, Liu
P, Wan L, Sarkar FH and Wei W: Skp2: A novel potential therapeutic
target for prostate cancer. Biochim Biophys Acta. 1825:11–17.
2012.PubMed/NCBI
|
9
|
Rose AE, Wang G, Hanniford D, Monni S, Tu
T, Shapiro RL, Berman RS, Pavlick AC, Pagano M, Darvishian F, et
al: Clinical relevance of SKP2 alterations in metastatic melanoma.
Pigment Cell Melanoma Res. 24:197–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Schüler S, Diersch S, Hamacher R, Schmid
RM, Saur D and Schneider G: SKP2 confers resistance of pancreatic
cancer cells towards TRAIL-induced apoptosis. Int J Oncol.
38:219–225. 2011.PubMed/NCBI
|
11
|
Osoegawa A, Yoshino I, Tanaka S, Sugio K,
Kameyama T, Yamaguchi M and Maehara Y: Regulation of p27 by S-phase
kinase-associated protein 2 is associated with aggressiveness in
non-small-cell lung cancer. J Cinical Oncol. 22:4165–4173. 2004.
View Article : Google Scholar
|
12
|
Wang Z, Fukushima H, Inuzuka H, Wan L, Liu
P, Gao D, Sarkar FH and Wei W: Skp2 is a promising therapeutic
target in breast cancer. Front Oncol. 1:187022012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Tian YF, Chen TJ, Lin CY, Chen LT, Lin LC,
Hsing CH, Lee SW, Sheu MJ, Lee HH, Shiue YL, et al: SKP2
overexpression is associated with a poor prognosis of rectal cancer
treated with chemoradiotherapy and represents a therapeutic target
with high potential. Tumor Biol. 34:1107–1117. 2013. View Article : Google Scholar
|
14
|
Hershko DD: Oncogenic properties and
prognostic implications of the ubiquitin ligase Skp2 in cancer.
Cancer. 112:1415–1424. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Timmerbeul I, Garrett-Engele CM, Kossatz
U, Chen X, Firpo E, Grünwald V, Kamino K, Wilkens L, Lehmann U,
Buer J, et al: Testing the importance of p27 degradation by the
SCFskp2 pathway in murine models of lung and colon cancer. Proc
Natl Acad Sci USA. 103:14009–14014. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yokoi S, Yasui K, Mori M, Iizasa T,
Fujisawa T and Inazawa J: Amplification and overexpression of SKP2
are associated with metastasis of non-small-cell lung cancers to
lymph nodes. Am J Pathol. 165:175–180. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hewitt SM: Tissue microarrays as a tool in
the discovery and validation of predictive biomarkers. Methods Mol
Biol. 823:201–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
|
19
|
Robinson MD and Oshlack A: A scaling
normalization method for differential expression analysis of
RNA-seq data. Genome Biol. 11:R252010. View Article : Google Scholar : PubMed/NCBI
|
20
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
da Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Costacou T, Lopes-Virella MF, Zgibor JC,
Virella G, Otvos J, Walsh M and Orchard TJ: Markers of endothelial
dysfunction in the prediction of coronary artery disease in type 1
diabetes. The Pittsburgh epidemiology of diabetes complications
study. J Diabetes Complications. 19:183–193. 2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Campbell JD, Alexandrov A, Kim J, Wala J,
Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, et
al: Distinct patterns of somatic genome alterations in lung
adenocarcinomas and squamous cell carcinomas. Nat Genet.
48:607–616. 2016. View
Article : Google Scholar : PubMed/NCBI
|
27
|
Liu J, Yang XY and Shi WJ: Identifying
differentially expressed genes and pathways in two types of
non-small cell lung cancer: Adenocarcinoma and squamous cell
carcinoma. Genet Mol Res. 13:95–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Su L, Han D, Wu J and Huo X: Skp2
regulates non-small cell lung cancer cell growth by Meg3 and
miR-3163. Tumour Biol. 37:3925–3931. 2016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Takanami I: The prognostic value of
overexpression of Skp2 mRNA in non-small cell lung cancer. Oncol
Rep. 13:727–731. 2005.PubMed/NCBI
|
30
|
Zhu CQ, Blackhall FH, Pintilie M, Iyengar
P, Liu N, Ho J, Chomiak T, Lau D, Winton T, Shepherd FA and Tsao
MS: Skp2 gene copy number aberrations are common in non-small cell
lung carcinoma, and its overexpression in tumors with ras mutation
is a poor prognostic marker. Clin Cancer Res. 10:1984–1991. 2004.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Jiang F, Todd NW, Li R, Zhang H, Fang H
and Stass SA: A panel of sputum-based genomic marker for early
detection of lung cancer. Cancer Prev Res (Phila). 3:1571–1578.
2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Chiang IT, Wang WS, Liu HC, Yang ST, Tang
NY and Chung JG: Curcumin alters gene expression-associated DNA
damage, cell cycle, cell survival and cell migration and invasion
in NCI-H460 human lung cancer cells in vitro. Oncology Rep.
34:1853–1874. 2015. View Article : Google Scholar
|